Travocort

Krajina: Arménsko

Jazyk: angličtina

Zdroj: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Aktívna zložka:

isoconazole (isoconazole nitrate), diflucortolone (diflucortolone valerate)

Dostupné z:

Bayer Healthcare Manufacturing S.r.l.

INN (Medzinárodný Name):

isoconazole (isoconazole nitrate), diflucortolone (diflucortolone valerate)

Dávkovanie:

10mg/g+1mg/g

Forma lieku:

cream for external use

Typ predpisu:

Prescription

Súhrn charakteristických

1/8
Travocort, cream
Summary of Product Characteristics
TRAVOCORT CREAM
Isoconazole nitrate plus Diflucortolone valerate
2/8
Travocort, cream
TABLE OF CONTENTS
1.
NAME OF THE MEDICINAL PRODUCT
........................................................... 4
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION IN TERMS OF
THE ACTIVE SUBSTANCE(S)
..............................................................................
4
3.
PHARMACEUTICAL FORM
.................................................................................
4
4.
CLINICAL PARTICULARS
...................................................................................
4
4.1
INDICATION(S)
...............................................................................................................
4
4.2
DOSAGE AND METHOD OF ADMINISTRATION
.....................................................................
4
4.3
CONTRAINDICATIONS
......................................................................................................
4
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
............................................................... 4
4.5
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION ......... 5
4.6
PREGNANCY AND
LACTATION............................................................................................
5
4.6.1
PREGNANCY
.................................................................................................................
5
4.6.2
LACTATION...................................................................................................................
5
4.7
EFFECTS ON ABILITY TO DRIVE OR USE
MACHINES..............................................................
5
4.8
UNDESIRABLE
EFFECTS.....................................................................................................
5
4.9
OVERDOSE
.....................................................................................................................
6
5.
PHARMACOLOGICAL PROPERTIES
.......................................................